At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 80 enrolled
Drug / intervention
Budesonide +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Impact Of The Addition Of Budesonide To Low-Pressure, High-Volume Saline Sinus Irrigation For Chronic Rhinosinusitis
In Brief
A Phase 4 clinical trial evaluating Budesonide and Saline alone for Rhinosinusitis and 2 related conditions. Completed, enrolled 80 participants across 1 site.
Detailed Summary
The goal of this research project is to explore the impact of the addition of budesonide to high-volume, low-pressure nasal sinus saline irrigation (aka "Neti-Pot"-type systems) for patients with chronic rhinosinusitis with or without nasal polyps.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartJan 2016
First PostedMar 2016
Primary CompletionApr 2017
TodayJul 2026
First PostedMar 2, 2016
Enrollment StartJan 1, 2016
Primary CompletionApr 13, 2017
TodayJul 1, 2026
Enrollment to primary: 1.3 yearsPosted 10.3 years ago
Interventions
Budesonidedrug
Participants will undergo 4-week treatment course that includes budesonide powder added to saline rinse.
Saline alonedrug
Participants will undergo 4-week treatment course that includes lactose (placebo) powder added to saline rinse.